Twist Bioscience stock hits 52-week high at 143.1 USD
Twist Bioscience's stock price has reached a 52-week high of $143.1, drawing significant market attention following the announcement of this news.
On 2026-09-03, with the closing price at $128.71 remaining below the resistance level of $142.84, we judged that upside potential still remains. Although the RSI of 77.9 signals overbought conditions, we considered a buy in anticipation of a possible breakout above the resistance level, taking into account that trading volume surged to 2.28 times the 20-day average and the 7-day rate of change stood at +23.1%.
If the price reaches the resistance level of $142.84, take profit; if the price falls to the support level of $80.59, cut losses. These two price levels are the resistance and support levels calculated by REPORTING, and each position is closed when the respective condition is met.
RSI(14) at 77.9 (overbought territory, but strong momentum), moving averages in bullish alignment (uptrend), trading volume at 2.28x the 20-day average (expanding buying pressure), recent 7-day change of +23.1% (sustained upward price momentum)
None
The actual result of -10.8% deviated significantly from the predicted return of 3.5%. While the expectation of a sharp price rise was somewhat supported by the recent surge in trading volume and the rising 7-day rate of change, the analysis overlooked that, despite the RSI being in overbought territory at 77.9, no breakout materialized and the stop-loss level was reached.
In future trades, entry should be withheld when overbought signals appear strongly, and entry should be considered only after confirmation of a resistance breakout. In addition, it is necessary to set stop-loss levels closer to limit losses, and to take positions only after further confirming whether the surge in trading volume is sustained.